AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals
Axsome enters into a settlement agreement with Hikma Pharmaceuticals to resolve a patent litigation related to Sunosi.…
22,400€
-3,86%
Echtzeit-Aktienkurs Hikma Pharmaceuticals PLC
Bid:
Ask:
Nachrichten zur Hikma Pharmaceuticals PLC Aktie
Hikma shares fall 5% as stock succumbs to profit taking after strong results and outlook statement
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares fell five per cent in early trading as investors took profits despite the company…
Investing in Hikma Pharmaceuticals (LON:HIK) five years ago would have delivered you a 38% gain
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...…
Hikma Pharmaceuticals PLC (HKMPF) Q2 2024 Pre-Recorded Presentation Transcript
…
Hikma Pharmaceuticals shares surge on upbeat guidance By Investing.com
Hikma Pharmaceuticals shares surge on upbeat guidance…
Hikma Pharmaceuticals rallies following bullish first-half earnings
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares bounced 7.6% higher on Thursday following publication of its half-year financial report. “We had…
Hikma Pharma buys Xellia assets for US$135m
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) has bought a raft of US injectable or finished dosage form (FDF) assets from Copenhagen-based…
Hikma beefs up complex manufacturing skillset with Xellia assets
Hikma Pharmaceuticals has bought a raft of US injectable or finished dosage form (FDF) assets from Copenhagen-based Xellia Pharmaceuticals for US$135...…